Insiders · OTLK

OTLK insider transactions

Outlook Therapeutics Inc. (OTLK) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for OTLK

• 5d
  Director Haddadin Yezan Munther bought $24,145 worth of shares (29,000 units at $0.83), increasing direct ownership by 78% to 66,167 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 7d
  Director Sukhtian Ghiath M. bought $5,000,000 worth of shares (8,539,709 units at $0.59) (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 12d
  Director Sukhtian Faisal Ghiath bought $50,006 worth of shares (122,174 units at $0.41), increasing direct ownership by 3,593% to 125,574 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 12d
  Director Haddadin Yezan Munther bought $14,960 worth of shares (34,000 units at $0.44), increasing direct ownership by 1,074% to 37,167 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 12d
  Director Thurman Randy H bought $2,145 worth of shares (5,000 units at $0.43), increasing direct ownership by 843% to 5,593 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 12d
  Director Hilzinger Kurt J bought $176,520 worth of shares (400,000 units at $0.44), increasing direct ownership by 1,691% to 423,655 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 248d
  SEC Form 4 filed by Director Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 248d
  SEC Form 4 filed by Director Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 248d
  SEC Form 4 filed by Director Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 248d
  SEC Form 4 filed by Director Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 248d
  SEC Form 4 filed by Director Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 248d
  SEC Form 4 filed by Director Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 248d
  SEC Form 4 filed by Director Thurman Randy H

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 248d
  SEC Form 4 filed by Director Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 334d
  SEC Form 4 filed by Chief Executive Officer Jahr Robert Charles

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 334d
  SEC Form 3 filed by new insider Jahr Robert Charles

  3 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 376d
  Director Sukhtian Ghiath M. was granted 4,285,714 shares (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 453d
  Amendment: Director Sukhtian Ghiath M. exercised 3,458,571 shares at a strike of $2.51 (SEC Form 4)

  4/A - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 487d
  SEC Form 4 filed by Director Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 502d
  SEC Form 4 filed by Director Sukhtian Ghiath M.

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 613d
  SEC Form 4 filed by Director Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 613d
  SEC Form 4 filed by Director Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 613d
  SEC Form 4 filed by Director Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 613d
  SEC Form 4 filed by Director Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 613d
  SEC Form 4 filed by Director Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 613d
  SEC Form 4 filed by Director Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 613d
  SEC Form 4 filed by Director Thurman Randy H

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 613d
  SEC Form 4 filed by Director Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 616d
  Chief Financial Officer Kenyon Lawrence A bought $28,446 worth of shares (5,000 units at $5.69), increasing direct ownership by 529% to 5,946 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 782d
  Syntone Ventures Llc bought 714,286 shares, increasing direct ownership by 72% to 1,705,438 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 801d
  Haddadin Yezan Munther bought $22,242 worth of shares (1,882 units at $11.82), increasing direct ownership by 59% to 5,049 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 808d
  SEC Form 4 filed by Kenyon Lawrence A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 808d
  SEC Form 4 filed by Evanson Jeff

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 808d
  SEC Form 4 filed by Trenary C Russell Iii

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 810d
  Sukhtian Ghiath M. was granted 2,305,714 shares (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 819d
  Evanson Jeff bought $26,243 worth of shares (62,484 units at $0.42), increasing direct ownership by 8% to 808,459 units (SEC Form 4)

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 822d
  SEC Form 4 filed by Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 822d
  SEC Form 4 filed by Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 822d
  SEC Form 4 filed by Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 822d
  SEC Form 4 filed by Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 822d
  SEC Form 4 filed by Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 822d
  SEC Form 4 filed by Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 822d
  SEC Form 4 filed by Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 822d
  SEC Form 4 filed by Thurman Randy H

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 977d
  SEC Form 4 filed by Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 977d
  SEC Form 4 filed by Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 977d
  SEC Form 4 filed by Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 977d
  SEC Form 4 filed by Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 977d
  SEC Form 4 filed by Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 977d
  SEC Form 4 filed by Sukhtian Faisal Ghiath

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 977d
  SEC Form 4 filed by Hilzinger Kurt J

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1144d
  SEC Form 4 filed by Dagnon Terry

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1146d
  SEC Form 4 filed by Dagnon Terry

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1146d
  SEC Form 4 filed by Evanson Jeff

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1146d
  SEC Form 4 filed by Trenary C Russell Iii

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1165d
  SEC Form 4 filed by Haddadin Yezan Munther

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1165d
  SEC Form 4 filed by Haller Julia A

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1165d
  SEC Form 4 filed by Huang Andong

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1165d
  SEC Form 4 filed by Auffarth Gerd

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)
• 1165d
  SEC Form 4 filed by Gangolli Julian S

  4 - Outlook Therapeutics, Inc. (0001649989) (Issuer)